8-K
Current Report
Merck & Co., Inc. Filed Acc 0000950123-06-007243
Exit or restructuring costs · Impairment
- Item 2.05 Costs associated with exit or disposal activities
- Item 2.06 Material impairments
From the SEC's structured data for this filing
Loading y21888e8vk.htm…